PharmGen Science, Inc. (004720.KS)
KRW 4370.0
(-1.47%)
KRW 4370.0
(-1.47%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 96.19 Billion KRW | 18.32% |
| 2022 | 81.3 Billion KRW | 33.71% |
| 2021 | 60.8 Billion KRW | 13.44% |
| 2020 | 53.59 Billion KRW | 6.35% |
| 2019 | 50.39 Billion KRW | 9.09% |
| 2018 | 46.2 Billion KRW | 12.0% |
| 2017 | 41.25 Billion KRW | 3.19% |
| 2016 | 39.97 Billion KRW | 23.55% |
| 2015 | 32.35 Billion KRW | 35.5% |
| 2014 | 23.87 Billion KRW | 8.78% |
| 2013 | 21.95 Billion KRW | 34.77% |
| 2012 | 16.28 Billion KRW | 6.58% |
| 2011 | 15.28 Billion KRW | -47.54% |
| 2010 | 29.13 Billion KRW | -6.3% |
| 2009 | 31.09 Billion KRW | 2.16% |
| 2008 | 30.43 Billion KRW | 8.09% |
| 2007 | 28.16 Billion KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 26.33 Billion KRW | 4.61% |
| 2024 Q1 | 25.71 Billion KRW | -4.29% |
| 2023 Q4 | 26.86 Billion KRW | 12.46% |
| 2023 Q1 | 21.82 Billion KRW | 0.4% |
| 2023 Q2 | 24.87 Billion KRW | 13.98% |
| 2023 Q3 | 23.88 Billion KRW | -3.97% |
| 2023 FY | 96.19 Billion KRW | 18.32% |
| 2022 Q4 | 21.73 Billion KRW | 9.54% |
| 2022 Q3 | 19.84 Billion KRW | 3.65% |
| 2022 Q2 | 19.14 Billion KRW | -6.99% |
| 2022 Q1 | 20.58 Billion KRW | 15.31% |
| 2022 FY | 81.3 Billion KRW | 33.71% |
| 2021 Q3 | 15.53 Billion KRW | 2.99% |
| 2021 Q2 | 15.08 Billion KRW | 22.38% |
| 2021 Q1 | 12.32 Billion KRW | -17.31% |
| 2021 FY | 60.8 Billion KRW | 13.44% |
| 2021 Q4 | 17.84 Billion KRW | 14.88% |
| 2020 Q2 | 13.41 Billion KRW | 9.17% |
| 2020 FY | 53.59 Billion KRW | 6.35% |
| 2020 Q4 | 14.9 Billion KRW | 14.74% |
| 2020 Q3 | 12.99 Billion KRW | -3.13% |
| 2020 Q1 | 12.28 Billion KRW | 1.5% |
| 2019 Q4 | 12.1 Billion KRW | -1.33% |
| 2019 Q2 | 13.67 Billion KRW | 10.75% |
| 2019 FY | 50.39 Billion KRW | 9.09% |
| 2019 Q1 | 12.34 Billion KRW | -0.45% |
| 2019 Q3 | 12.26 Billion KRW | -10.31% |
| 2018 Q4 | 12.4 Billion KRW | 13.03% |
| 2018 FY | 46.2 Billion KRW | 12.0% |
| 2018 Q2 | 11.7 Billion KRW | 5.29% |
| 2018 Q3 | 10.97 Billion KRW | -6.23% |
| 2018 Q1 | 11.11 Billion KRW | 2.22% |
| 2017 Q2 | 10.06 Billion KRW | 4.2% |
| 2017 FY | 41.25 Billion KRW | 3.19% |
| 2017 Q4 | 10.87 Billion KRW | 2.02% |
| 2017 Q3 | 10.65 Billion KRW | 5.93% |
| 2017 Q1 | 9.65 Billion KRW | -12.19% |
| 2016 Q1 | 10.07 Billion KRW | 23.67% |
| 2016 Q3 | 9.34 Billion KRW | -2.18% |
| 2016 Q4 | 10.99 Billion KRW | 17.67% |
| 2016 Q2 | 9.55 Billion KRW | -5.21% |
| 2016 FY | 39.97 Billion KRW | 23.55% |
| 2015 Q4 | 8.14 Billion KRW | 6.95% |
| 2015 FY | 32.35 Billion KRW | 35.5% |
| 2015 Q3 | 7.61 Billion KRW | -10.04% |
| 2015 Q2 | 8.47 Billion KRW | 4.35% |
| 2015 Q1 | 8.11 Billion KRW | 48.72% |
| 2014 Q3 | 6.43 Billion KRW | 5.55% |
| 2014 Q2 | 6.1 Billion KRW | 3.7% |
| 2014 FY | 23.87 Billion KRW | 8.78% |
| 2014 Q1 | 5.88 Billion KRW | 40.09% |
| 2014 Q4 | 5.45 Billion KRW | -15.23% |
| 2013 Q3 | 5.75 Billion KRW | -14.23% |
| 2013 Q4 | 4.19 Billion KRW | -27.06% |
| 2013 FY | 21.95 Billion KRW | 34.77% |
| 2013 Q1 | 5.28 Billion KRW | 86.73% |
| 2013 Q2 | 6.71 Billion KRW | 27.02% |
| 2012 Q4 | 2.82 Billion KRW | -42.63% |
| 2012 FY | 16.28 Billion KRW | 6.58% |
| 2012 Q2 | 3.75 Billion KRW | -22.45% |
| 2012 Q3 | 4.93 Billion KRW | 31.44% |
| 2012 Q1 | 4.83 Billion KRW | 57.92% |
| 2011 Q1 | 5.39 Billion KRW | -6.04% |
| 2011 Q4 | 3.06 Billion KRW | -25.4% |
| 2011 FY | 15.28 Billion KRW | -47.54% |
| 2011 Q2 | 2.71 Billion KRW | -49.68% |
| 2011 Q3 | 4.1 Billion KRW | 51.29% |
| 2010 Q3 | 5.9 Billion KRW | -33.2% |
| 2010 Q2 | 8.83 Billion KRW | 4.74% |
| 2010 Q1 | 8.43 Billion KRW | 42.6% |
| 2010 FY | 29.13 Billion KRW | -6.3% |
| 2010 Q4 | 5.74 Billion KRW | -2.68% |
| 2009 Q2 | 7.82 Billion KRW | 2.24% |
| 2009 Q4 | 5.91 Billion KRW | -39.01% |
| 2009 Q3 | 9.69 Billion KRW | 23.87% |
| 2009 Q1 | 7.65 Billion KRW | 32.85% |
| 2009 FY | 31.09 Billion KRW | 2.16% |
| 2008 Q1 | 9.15 Billion KRW | 46.27% |
| 2008 Q3 | 7.86 Billion KRW | 2.61% |
| 2008 Q4 | 5.76 Billion KRW | -26.68% |
| 2008 FY | 30.43 Billion KRW | 8.09% |
| 2008 Q2 | 7.66 Billion KRW | -16.31% |
| 2007 Q4 | 6.25 Billion KRW | 9.34% |
| 2007 Q2 | 7.53 Billion KRW | -12.88% |
| 2007 FY | 28.16 Billion KRW | 0.0% |
| 2007 Q3 | 5.72 Billion KRW | -24.02% |
| 2007 Q1 | 8.64 Billion KRW | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Daewoong Co., Ltd. | 931.19 Billion KRW | 89.669% |
| Wooridul Huebrain Limited | 2.52 Billion KRW | -3717.221% |